FLORIDA SOCIETY OF HEALTH SYSTEM PHARMACISTS NOVEMBER 4, 2016 JAMES T WAGNER CONTROLLED ENVIRONMENT CONSULTING
|
|
- Grace Newton
- 6 years ago
- Views:
Transcription
1 Engineering Controls for Compliance with USP Chapters <797> and <800> FLORIDA SOCIETY OF HEALTH SYSTEM PHARMACISTS NOVEMBER 4, 2016 JAMES T WAGNER CONTROLLED ENVIRONMENT CONSULTING
2 Learning and Performance Objectives At the end of this session, you will be able to: Distinguish between primary and secondary engineering controls in the sterile compounding controlled environments. Utilize knowledge about the principles of airflow to compound with proper aseptic technique using first air regardless of the type of primary engineering control. Describe the function of HEPA filters in cleanroom environments and the application of airflow principles to create a sterile compounding environment Differentiate ISO Class 5, ISO Class 7 and ISO Class 8 work environments as related to cleanliness and particulate counts. Outline the different types of laminar airflow work centers (LAFWs) that may be utilized when preparing CSPs. Integrate an understanding of the term state of control into the certification report for primary and secondary engineering controls.
3 Engineering Controls Engineering controls eliminate or reduce the potential exposure of a product or personnel to contamination or a hazard through the use of engineered equipment or machinery Primary: Point of use Secondary: Facility design
4 Definitions Positive Pressure Net displacement of air out of the space Negative Pressure Net displacement of air into the space State of Control Points Engineering issues that affect room performance i.e. provide adequate HEPA filtered air to a cleanroom Desired Outcomes Objectives of state of control engineering criteria i.e. maintain an ISO class 7 buffer room
5 Primary Engineering Controls Laminar Air Flow Workbench Biological Safety Cabinet (BSC) Compounding Aseptic Isolator (CAI & CACI)
6 Engineering Controls Engineering controls employed in sterile compounding use Airflow through High Efficiency Particulate Air (HEPA) filters to create air of appropriate Cleanliness Classification Airflow Filtration Cleanliness Classification Maintain a State of Control to obtain and confirm the Desired Outcome (Objective)
7 Airflow Definitions Unidirectional flow Flow control to eliminate particles from critical work sites HEPA-filtered air should be supplied in critical areas at a velocity sufficient to sweep particles away from the compounding area and maintain unidirectional airflow during operations. Laminar vs. Unidirectional
8 Airflow Definitions (continued) Proper design and control prevents turbulence and stagnant air in the critical area In situ air-pattern analysis via smoke studies shall be conducted at the critical area to demonstrate unidirectional airflow and sweeping action over and away from the product under dynamic (working) conditions
9 Airflow Definitions (continued) Turbulent flow Dilution control to reduce particulate levels Adequate HEPA-filtered airflow supplied to the cleanroom and anteroom is required to maintain cleanliness classification during operational activity
10 HEPA Filter Specifications IEST-RP-CC001.5 Performance Levels: Type C Filter Tested for overall penetration and have been leak tested. Minimum filter efficiency is 99.99% on 0.3 µm particles Type K Filter Tested for overall penetration per IEST-RP-007 and has been leak tested. Minimum efficiency is % at either µm or µm particle size
11 Cleanliness Classification* Class Name Particle Count ISO Class FS 209E ISO m 3 FS 209E, ft 3 3 Class Class Class Class , Class 10, ,000 10,000 8 Class 100,000 3,520, ,000 *Classification of Particulate Matter in Room Air Limits are in particles 0.5 µm and larger per cubic meter (current ISO ) and cubic feet (former Federal Standard 209E) measured under dynamic operating conditions.
12 Cleanliness Classification (continued) <797> Environmental and Quality Control Ante Area ISO Class 7 or 8 Sterile preparations must be manipulated in an ISO Class 5 environment (Class 100) or better The ISO Class 5 environment is housed in an ISO Class 7 (Class 10,000) or better environment The ante areas are at least ISO class 8 (Class 100,000) Buffer Area ISO Class 7 PEC ISO Class 5 DCA Direct Compounding Area
13 Cleanliness Classification (continued) Particle Count Parameters ISO As-built, At-rest, Operational USP <797> counts to be taken during operations Particle size USP <797> 0.5µ and larger Locations ISO or Federal Std. 209E Based on room size for general room classification Not more than 1 foot away from the work site, within the airflow for critical site dynamic operating counts.
14 First Air: Utilizing Unidirectional Airflow The advantages of unidirectional airflow should be exploited when considering placement of materials within the DCA. The use of unidirectional airflow can be used to prevent cross contamination within the DCA. First Air Zone Nothing to be placed between the HEPA filter and the critical compounding zone Zone of Confusion Turbulent area downstream of an obstruction possible source of cross contamination
15 First Air Improper hand placement disrupts first air
16 First Air (continued) Proper hand placement takes advantage of first air
17 Primary Engineering Controls (PECs) Laminar Air Flow Workbench (LAFW)
18 Placement of Primary Engineering Controls The primary engineering control should be placed within a buffer room in a manner to avoid conditions that could adversely affect its operation such as: Doors opening and closing Personnel traffic Cross drafts from HVAC Impact of other airflow devices
19 Primary Engineering Controls (continued) Compounding Aseptic Isolator Isolator specifically designed for compounding pharmaceutical preparations. Maintains an aseptic compounding environment inside the isolator throughout the compounding and material transfer processes. Air exchange from the surrounding environment should not occur unless the air has first passed through a microbial retentive filter (HEPA minimum). Compounding Aseptic Isolator (CAI)
20 Primary Engineering Controls Compounding Aseptic Containment Isolators (CACI) Designed to provide worker protection and to provide an aseptic environment. If volatile drugs are prepared, the exhaust air from the isolator should be appropriately removed by properly designed building ventilation.
21 Isolator Airflow Design The airflow in the PEC shall be unidirectional (laminar flow) This requirement applies to ALL PECS Turbulent Flow CAI Unidirectional Flow CAI Airflow Schematics Courtesy of Germfree Laboratories
22 Compounding Isolators Compounding Aseptic Isolators must be placed in an ISO Class 7 cleanroom unless they meet all of the following conditions: Must provide isolation from the room Must maintain ISO class 5 during dynamic operating conditions Transferring ingredients into and out of the isolator and during preparation of CSPs. Tests to prove above conditions are detailed in CETA CAG
23 Positive Pressure CAI Most positive pressure isolators provide product protection only. HEPA filtered supply air provides at least ISO Class 5 conditions
24 Isolator Work-Practice Considerations Isolators may be located in either a classified or unclassified space Need to establish SOPs to reduce the chance of bringing contamination into the isolator by compromising the barrier Procedures will vary by isolator design (unidirectional vs. turbulent, pass-through) Ingress and egress of material Recovery (purge) time Cleaning and disinfection protocol
25 NIOSH Requirements For HD PEC Selection When asepsis is required or is the recommended work practice, the use of ventilated cabinets designed for both hazardous drug containment and asepsis is recommended The recommended ventilated cabinets include Class II Type B2, Class III BSC, and aseptic containment isolators Class II Type B2 BSC Class III BSC Negative Pressure CACI
26 NIOSH Requirements For HD PEC Selection Type A2 and B1 cabinets are allowed under certain conditions A ventilated cabinet with air recirculation, either within the cabinet or to the room environment, should only be used if the hazardous drugs in use will not volatize during process manipulations or after capture by the HEPA filter
27 Canopy Connection & Audible Alarm Requirement Enforced as of 4/15/2016 Class II, Type A BSC Direct-connection previous allowed was eliminated Requirement added for an audible alarm to canopy-connected Type A cabinets These requirements came out in 2011 but have not been enforced by field certifiers NSF encourages: Organizations using Class II cabinets to conduct internal risk assessment New cabinets manufactured must provide an alarm on these units Retrofit older cabinets in the field to conform with the audible alarm requirement NSF accredited field certifiers who certify a direct-connected Type A BSC or a nonalarmed canopy-connected Type A BSC will be considered in violation of code of conduct
28 Chapter <800> Requirements for HD PEC Selection All C-PECs used for manipulation of sterile HDs must be externally vented. Class II, Type A2, B1, B2, Class III BSC, and CACI are all acceptable. For most known HDs, Type A2 BSCs offer a simple and reliable integration with the ventilation and pressurization requirements of the C-SEC. A2 BSC less exhaust airflow than B2 B2 BSC adds complexity and do not integrate well in small rooms CACI risk contamination if leak in glove, sleeve or cabinet
29 Primary Engineering Control User Suggestions Primary engineering controls should not be turned off If turned off Requires recovery time Air-balance of room for externally vented devices Pre-filter change cycle Cleanliness of room Position of pre-filter on device Understand the monitoring gauges Magnehelic Gauge
30 Primary Engineering Control Applications
31 Primary Engineering Control Applications
32 Primary Engineering Control Applications
33 Summary Your choice of primary engineering control should be based on processes, with concessions given to protection of compounding personnel and environment. Engineering controls must be properly integrated into the facility and certified to be functioning correctly.
34 Secondary Engineering Controls Sterile Compounding Boot Camp
35 Learning and Performance Objectives At the end of this session, you will be able to: Explain the facility and environmental requirements for compounding sterile preparations for each of the three risk levels outlined in USP <797>. Differentiate the engineering controls used in the preparation of nonhazardous versus hazardous compounded sterile preparations. Summarize how the primary and secondary engineering controls work together to contribute to the overall sterile compounding facility state of control.
36 Secondary Engineering Controls Traditional ISO class 7 Buffer room with (Laminar Airflow Work hood) LAFW ISO class 7 Buffer room with Integral ISO class 5 Vertical Laminar Flow (VLF)
37 Facility Requirements The facility design must ensure: the ability to get components into the primary engineering control without introduction of contamination into the Direct Compounding Area (DCA) the ability to provide a safe working environment to the compounding staff and to protect the environment from products produced
38 Direct Compounding Area (DCA) No brown corrugated cardboard in controlled areas. White, plastic-coasted boxes limited to the ante-room and the hazardous drug buffer room. When unpacked from any shipping containers, components wiped down with an appropriate disinfectant (preferably a sporicidal) in general prep area or on dirty side of anteroom before moving across line of demarcation into the buffer room. Components are wiped again with sterile IPA just prior to being placed inside the ISO class 5 device. Nothing but sterile components and disinfected materials are moved into the DCA within the ISO class 5 device.
39 Activity of unwrapping to left or right of DCA Ante room Typically ISO 7 or 8 Buffer room Typically ISO 7 General Prep Area Non classed Wipe surfaces with sipa just prior to placing in PEC D C A ISO Class 5 PEC Wipe surfaces with agent that can disinfect (preferably with activity against mold spores)
40 Airflow Definitions Turbulent flow Dilution control to reduce particulate levels Adequate HEPA filtered airflow supplied to the cleanroom and anteroom is required to maintain cleanliness classification during operational activity
41 Secondary Engineering Controls The buffer area (a.k.a., cleanroom) must maintain at least ISO class 7 conditions for 0.5µm and larger particles under dynamic operating conditions Non-hazardous applications The ante room must meet at least ISO class 8 Hazardous applications The ante room must meet at least ISO class 7
42 Ante-Area Non-hazardous applications: Anteroom must achieve at least ISO class 8 conditions & be positive pressure to uncontrolled spaces Negative to compounding room
43 Ante-Area Hazardous applications: Anteroom must achieve at least ISO class 7 & be positive to uncontrolled spaces Positive to the HD compounding room
44 Secondary Engineering Controls Segregation The room must be segregated from surrounding, unclassified spaces to reduce the risk of contaminants being blown, dragged, or otherwise introduced into the filtered unidirectional airflow environment, and this segregation shall be continuously monitored. Physical separation 0.02 to 0.05 inches water column (w.c.) positive pressure Open concept (Displacement airflow) 40 feet per minute (fpm) across the line of demarcation May not be applied in high risk level compounding applications
45 Secondary Engineering Controls High Risk application Differential pressure controlled Low Risk application Displacement flow controlled
46 Secondary Engineering Controls Adequate HEPA filtered airflow supplied to the cleanroom and anteroom is required to maintain cleanliness classification during operational activity through the number of air changes per hour. Minimum of 30 HEPA filtered Air Changes Per Hour (ACPH) in Buffer Area No less than 15 ACPH must be provided as fresh HEPA air supplied through the room s HVAC system This assumes additional HEPA filtered air is provided to the room through the primary engineering control. Supply airflow typically not continuously monitored Room pressure monitored
47 Common Airflow Distribution Options Low wall mounted returns are somewhat more difficult to install but are a great deal more efficient in removal of airborne particulate contamination. Low wall returns should be well distributed throughout the room and ideally have adjustable louvers or dampers. Turbulent Flow Low Wall Return Supply Supply Turbulent Flow - Ceiling Return Supply Return Supply Hepa Filter Hepa Filter Hepa Filter Hepa Filter Return Return
48 Ceiling mounted HEPA filters Low-wall mounted returns
49 Common Airflow Distribution Options A mixed flow cleanroom combines the ISO class 5 unidirectional primary engineering control space directly into the ISO class 7 turbulent flow room. The ISO class 5 area should be separated from the ISO class 7 space with a physical barrier such as a plastic or Plexiglas curtain. This design option is usually more flexible for positioning larger equipment. Mixed Flow Supply Supply Supply Hepa Filters Hepa Filter Return
50 Ventilation Efficiency Mixed Flow Room ISO class 7 space Turbulent flow ISO class 5 space Unidirectional airflow Relief gap to low wall returns
51 Cleanroom Design Elements HVAC system Most existing HVAC systems do not have the capacity to handle the additional demands of a cleanroom. An experienced HVAC engineer will need: Existing HVAC drawings and specs How many people will be working in room Process equipment BTU load Airflow requirements (required ACPH for each room) Filter requirements and specs Amount of air exhausted by engineering controls
52 Secondary Engineering Controls All HEPA filters should be efficiency tested at the most penetrating particle size leak tested at the factory and leak tested again in situ after installation. IEST type C or K HEPA filter CETA guide CAG for field certification Filter leak tested and repaired
53 Hazardous Drug (HD) Applications Hazardous drugs shall be stored separately from other inventory in a manner to prevent contamination and personnel exposure. Minimum of 12 ACPH Negative pressure The ISO class 5 BSC or CACI shall be placed in an ISO class 7 room that is physically separated, e.g., a different room from other preparation areas, and optimally has no less than 0.01 inches water column (w.c.) negative pressure to adjacent rooms. HD Buffer rooms housing CACIs must meet the minimum 0.01 w.c. negative pressure and 12 ACPH requirements.
54 HD Applications (continued) The BSC and CACI should be 100% vented outside of the facility See the Ventilated cabinet section in the NIOSH Alert & <800> NIOSH Alert also on thumb drive Accommodation for facilities that prepare a very low volume of HDs (e.g.,< 5 preparations/week) and use 2 tiers of containment (e.g., CSTD within a BSC or CAI) Separate negative pressure room not needed Note that the low-volume exemption is not recognized in <800> and the exemption goes away so consider other long term solutions
55 USP <800> Intent to Revise USP Expert Committee already approved this change: Removes requirement that the C-SEC be externally vented through highefficiency particulate air (HEPA) filtration Section 5.3 FACILITIES AND ENGINEERING CONTROLS, Compounding will be revised to indicate that the C-SEC used for sterile and nonsterile compounding must be externally vented but the C-SEC does not need to be vented through HEPA filtration
56 ISO Class 5 Sources, Buffer Areas, and Ante Areas Segregated Compounding Area Low risk level CSPs 12 hour BUD Low, Medium, or High Risk Level Compounding Facility <797> limits to non-hazardous applications, <800> adds HD SCA
57 Low Risk with 12 Hour or Less BUD Rooms Appropriate for non-hazardous low risk compounding only Area does not need to meet environmental conditions of a cleanroom Area must have: Sink for hand washing Sink can not be located adjacent to the ISO class 5 PEC Recent study findings demonstrate sink should be more than 3 feet away from any PEC* *Hota S, Hirji Z, Stockton K, Lemieux C, Dedier H, Wolfaardt G, Gardam MA. Outbreak of Multidrug Resistant Pseudomonas aeruginosa Colonization and Infection Secondary to Imperfect Intensive Care Unit Room Design. Infect Control Hosp Epidemiol 2009; 30:25 33.
58 Low Risk 12H BUD Rooms (continued) Area may not: Have unsealed windows or doors that connect to high traffic or outside space Be adjacent to construction sites Be adjacent to warehouses Be adjacent to food preparation
59 Ceilings Epoxy-coated gypsum board (sheet rock) Anodized aluminum T grid with cleanroom ceiling tiles Tiles must be caulked in place to ensure seal Caulking of individual ceiling tiles allows caulking to be removed so servicing can occur then re-caulked Smooth, non-porous tiles that stand up to disinfectants Wall junctions coved or caulked
60 Copyright CriticalPoint s Sterile Compounding Boot Camp - All rights reserved Use of this educational material by a 3rd party does not constitute endorsement by CriticalPoint or ClinicalIQ Lighting Cleanroom lighting Sealed Especially for negative pressure rooms Flush Mounted Easily cleaned
61 How will you get components in? How will you get finished CSPs out? Staff need to understand use Wall-mounted Cart pass-through
62 Pass Throughs Used to transfer materials from one room to another with limited particle transfer Materials of construction Interlocks Never allow both doors to open at same time
63 Pass-Through Usage/Location Pass-Through Position Classified to Classified Classified to Unclassified FDA Position BOP Positions
64 Pass-Throughs Possible solution Classified to Unclassified unclassified area directly over outer P/T door
65 Walls and General Considerations Epoxy-coated gypsum board Interlocking panels made of cleanroom-compatible materials Junction with floor to be coved and sealed. No ledges, gaps or right angles that make cleaning difficult Coving and wall joint should be flush Avoid flat horizontal surfaces that can collect dust Sills Horizontal exposed piping or conduit Large door jams and window frames Cabinets; use carts restocked 1-2 times daily with essential supplies only
66 Floors Wide-sheet vinyl flooring with heat-welded seams and coving to side walls Must withstand continuous cleaning with disinfectant agents No gaps or crevices for microorganisms to accumulate and grow No floor drains
67 LOD Applications Donning Doffing HD considerations
68 Floors (continued) Ideally coving and/or caulking at the base of all permanently mounted fixtures to facilitate cleaning If building from scratch, suggest line/s of demarcation built into floor with different color vinyl Coving Drywall 5/8 ½
69 Monitoring Differential Pressure Gauges Pressure differential from ISO Class 7 to non classed area must be a cascading pressure gradient 0.02 cleanroom to gowning (anteroom) 0.02 ante to prep area
70 Temperature Considerations Conditions that need to be taken into consideration when considering optimum temperature Operator comfort wearing appropriate garb Product considerations Typical cleanroom temperature range: 66º F to 72º F Range recommended for compounding pharmacies based on garbing required 64º F to 68º F
71 Humidity Considerations The amount of moisture in the air is critical. The factors to consider are: Microbial growth Effects on product and process Worker comfort Static electricity Typical values of cleanroom humidity range from 30% RH to 60% RH
72 Other Considerations Careful consideration should be given to placement of particle generators such as computers, printers and refrigerators. Material storage and prep Hand hygiene Gowning Line of demarcation
73 Facility Engineering Control Certification Certifier Qualification NSF Accreditation CNBT Accreditation Certification reference material Controlled Environment Testing Association (CETA) Do not allow certification personnel into your controlled environments without completing hand hygiene and garbing!
74 Summary Consider all of the primary engineering control options before designing the facility Design the facility to positively interact with your chosen primary engineering control
Compounding Aseptic Isolators (CAI) James T Wagner
Compounding Aseptic Isolators (CAI) James T Wagner jimwagner@cenvironment.com Disclaimer "Although I am a member of the USP Sterile Compounding Expert Committee, I am speaking today in my individual capacity
More informationSTANDARDS FOR COMPOUNDING PHARMACIES
STANDARDS FOR COMPOUNDING PHARMACIES APPLICATION NOTE LC-139 (US) Introduction This publication provides excerpts from some of the many guidelines and standards that pertain to compounding pharmacies.
More informationFacility Design for Pharmacy Operation. Full-Scale Nuclear. Slides are not to be reproduced without permission of author.
Facility Design for Pharmacy Operation Full-Scale Nuclear in a Hospital Setting Neil A. Petry, MS, RPh, BCNP, FAPhA Clinical i l Assistant t Professor in Radiology Director, Radiopharmacy Services Duke
More informationUSP <797>/<800> Cleanroom Design & Environmental Monitoring. A presentation for HealthTrust Members November 14, 2018
USP / Cleanroom Design & Environmental Monitoring A presentation for HealthTrust Members November 14, 2018 Andrew King, USP Compliance and Engineering Specialist CETA Member RCCP-SC Disclosures
More informationImproving the Safety of Compounded Preparations - USP <800> Compliance in Every Day Practice
Improving the Safety of Compounded Preparations - USP Compliance in Every Day Practice PSSNY Annual Convention, Westchester Hilton, Rye Brook, NY Sunday, June 25th at 9:00 AM Lou Diorio, RPh, FAPhA
More informationUSP <800> PRACTICAL COMPLIANCE STRATEGIES FOR ALL PRACTICE SETTINGS
USP PRACTICAL COMPLIANCE STRATEGIES FOR ALL PRACTICE SETTINGS NYSCHP Annual Assembly The Saratoga Hilton, Saratoga Springs, NY Sunday, April 22th at 8 AM LOU DIORIO, RPH, FAPHA PRINCIPAL LDT HEALTH
More informationDeveloped and Presented by: Wisconsin Healthcare Engineering Association
Infection Control Risk Assessment (ICRA) Developed and Presented by: Wisconsin Healthcare Engineering Association What is an ICRA? An Infection Control Risk Assessment is a tool devised to protect patients
More informationPHARMACY IV ADMIXTURE. Pharmacy 483 January 17, 2006 Kim Donnelly Affiliate Associate Professor
PHARMACY IV ADMIXTURE Pharmacy 483 January 17, 2006 Kim Donnelly Affiliate Associate Professor Pharmacist is responsible for ensuring that compounded sterile preparations are properly prepared, labeled,
More information2017 Diversion Specialists
2017 Diversion Specialists RUSSELL ODEGARD Chief Executive Officer DYNALABS RUSSELL ODEGARD Chief Executive Officer DYNALABS LOU DIORIO, RPh, FAPhA Principal LTD Health Solutions, Inc. Achieving Compliance
More informationPHARMACY IV ADMIXTURE
PHARMACY IV ADMIXTURE Pharmacy 483 January 18, 2007 Kim Donnelly Affiliate Assistant Professor kimdon@u.washington.edu Pharmacist is responsible for ensuring that compounded sterile preparations are properly
More informationGuidelines for Design of. Compounded Sterile Products (CSPs) Facility
State of Kuwait Ministry of Health Infection Control Directorate Task Force Group for Designs and Constructions of Health Care Facilities Guidelines for Design of Compounded Sterile Products (CSPs) Facility
More informationUSP 797 & 800 Pharmacy Overview. (Presented to Vermont Chapter of New England Healthcare Engineers May 2016)
USP 797 & 800 Pharmacy Overview (Presented to Vermont Chapter of New England Healthcare Engineers May 2016) Overview Background and Regulatory Need United States Pharmacopeia (USP) 797 Purpose/Goals USP
More informationSterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE)
Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE CriticalPoint s Sterile Compounding elearning curriculum is written by industry experts and covers both Chapter and
More informationCERTIFICATION REPORTS, WHAT DO I NEED TO KNOW?
Pharmacy Compounding Overview and Insanitary Conditions CERTIFICATION REPORTS, WHAT DO I NEED TO KNOW? 1 Introductions CDR Mary McGarry, BS, PharmD, MS, RAC, CPGP CDR Stacey Degarmo, PharmD, BCPS, CPH,
More informationBaxa Corporation. Technical Paper. Environmental Controls for Sterile Compounding
Baxa Corporation Environmental Controls for Sterile Compounding Technical Paper A guidance document on developing sterile preparation areas to meet the USP requirements for low and medium risk compounded
More informationPharmacy Quality Assurance Commission Sterile Compounding [USP <797>] Self-Assessment Compliance Checklist
STATE OF WASHINGTON Pharmacy Quality Assurance Commission Sterile Compounding [USP ] Self-Assessment Compliance Checklist Introduction: This checklist includes the reported principal competencies,
More informationSterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE)
Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE Fundamentals of Sterile Compounding (8 lessons/8 hours CE) The History of Compounding and USP Sterile Compounding Chapters
More informationCERTIFICATION REPORTS, WHAT DO I NEED TO KNOW?
Pharmacy Compounding Overview and Insanitary Conditions CERTIFICATION REPORTS, WHAT DO I NEED TO KNOW? 1 Introductions CDR Mary McGarry, BS, PharmD, MS, RAC, CPGP CDR Stacey Degarmo, PharmD, BCPS, CPH,
More informationTel: TTY: NOTICE OF PUBLIC HEARING
CHARLES D. BAKER Governor KARYN E. POLITO Lieutenant Governor The Commonwealth of Massachusetts Executive Office of Health and Human Services Department of Public Health Bureau of Health Professions Licensure
More informationLUNCH AND LEARN. October 14, CE Activity Information & Accreditation
LUNCH AND LEARN USP Chapter : What s on the Radar? October 14, 2016 Featured Speaker: Patricia C. Kienle, RPh, MPA, FASHP Director, Accreditation and Medication Safety Cardinal Health Innovative Delivery
More informationEnhanced Sterile Medication Compounding Evaluation
Enhanced Sterile Medication Compounding Evaluation Robert Campbell, PharmD Director, Standards Interpretation Hospital /Ambulatory Programs Director, Medication Management Division of Healthcare Quality
More informationUSP <797> Compliance Common Challenges and Potential Solutions
USP Compliance Common Challenges and Potential Solutions Angela Yaniv, Pharm.D Assistant Director - Sterile Products May 2, 2017 - OSHP Annual Meeting Angela Yaniv has no actual or potential conflict
More informationUSP <800> A practical approach to compliance. Ryan W. Naseman, PharmD, MS, BCPS Michael Storey, PharmD, MS, BCPS
USP A practical approach to compliance Ryan W. Naseman, PharmD, MS, BCPS Michael Storey, PharmD, MS, BCPS Learning Objectives Explain the need for USP from an employee safety standpoint Describe
More informationUSP CHAPTER <797> INTRODUCTION RISK LEVELS
USP CHAPTER INTRODUCTION RISK LEVELS Introduction: The objective of this chapter is to describe conditions and practices to prevent harm, including death, to patients that could result from 1) microbial
More informationForm 9: Infection Control Preventive Measures Level 4
Form 9: Infection Control This form is filled out by the construction planning team or designated person(s) to identify the required preventive measures for the activity described in Form 1 Infection Control
More informationINSPECTOR S OBSERVATIONS AND WARNING LETTER
Microrite, Inc. San Jose, CA, USA, http://www.microrite.com AIR VELOCITY MEASUREMENTS AND CORRELATION TO SMOKE STUDIES FOR ASEPTIC OPERATIONS KEYWORDS Air Velocity, Air Flows, Smoke Study, Air Pattern
More informationPosition: Sr. Director of Education and Data - NHIA, VP of Research - NHIF
Comment Submission Template for: General Chapter Pharmaceutical Compounding Sterile Preparations Revision proposed in Pharmacopeial Forum 41(6) Nov/Dec 2015 Send completed template to CompoundingSL@usp.org
More informationENFORCEMENT AND COMPOUNDING COMMITTEE REPORT June 2, 2017
California State Board of Pharmacy 1625 N. Market Blvd, N219, Sacramento, CA 95834 Phone: (916) 574-7900 Fax: (916) 574-8618 www.pharmacy.ca.gov BUSINESS, CONSUMER SERVICES AND HOUSING AGENCY DEPARTMENT
More informationSummary of USP* 797 Pharmaceutical Compounding Sterile Preparations
Summary of USP* 797 Pharmaceutical Compounding Sterile Preparations Source of base information Pharmacopeial Form Vol 29 (4) July Aug. 2003 Effective date January 1, 2004 FDA enforceable Scope The content
More informationPharmaceutical Compounding Sterile and Nonsterile Preparations. Jeanne Sun, PharmD
Pharmaceutical Compounding Sterile and Nonsterile Preparations Jeanne Sun, PharmD Agenda Legal Framework Overview Pharmaceutical Compounding Nonsterile Preparations Pharmaceutical Compounding
More informationFDA s Guidance for Industry
Sterile Drug Products Produced by Aseptic Processing - CGMPs Midwest FDC Conference November 4 2005 Susan Bruederle, Investigator FDA / ORA / Central Region Chicago District / Hinsdale IL FDA s Guidance
More informationj) Direct and Contiguous Compounding Area refers to the specific area where a compound is prepared.
Modified As a result of May 2011 Board meeting and discussion at Convention 61-02-01-03. Pharmaceutical compounding standards; again on September 13 th, 2011 by Katie Miller and reviewed at the September
More informationPhEn-602 Notes # 4 J. Manfredi
PhEn-602 Notes # 4 J. Manfredi Spring 2009 1 Basic definitions Clean Room: A room in which the concentration of airborne particles is controlled and contains one or more clean zones Clean Zone: A defined
More informationBRIEFING 797 PHARMACEUTICAL COMPOUNDING STERILE PREPARATIONS INTRODUCTION
1 of 58 8/20/2010 9:20 PM BRIEFING 797 Pharmaceutical Compounding Sterile Preparations, USP 32 page 318. As a result of frequently asked questions from compounding practitioners and continuous reassessment
More informationcompounding area based on environmental sampling and cleaning product type. Antiseptics and determine the appropriate use of each.
The pharmacist will be able to: 1. Determine a best practice for cleaning their compounding area based on environmental sampling and cleaning product type. 2. Discuss the difference between Disinfectants
More information116th Annual Convention
116th Annual Convention Date: Saturday, October 18, 2014 Time: 10:30 am 12:00 pm Location: Austin Convention Center, Room 16A, Level 4 Title: Activity Type: Speaker: Impetus for Change and Standards of
More informationImportant Updates in USP <797> and USP <823> Eric S. Kastango, MBA, BS Pharm, FASHP Clinical IQ, LLC & CriticalPoint, LLC Madison, New Jersey
Important Updates in USP and USP Eric S. Kastango, MBA, BS Pharm, FASHP Clinical IQ, LLC & CriticalPoint, LLC Madison, New Jersey Disclosures Principal-Clinical IQ, LLC Healthcare consulting
More informationSection 6.6 BSL3 & ABSL3 Biocontainment
NIH Design Requirements Manual 8-22-12 Section 6.6 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 Section 6.6
More informationLUNCH AND LEARN. September 11, CE Activity Information & Accreditation
LUNCH AND LEARN Environmental Monitoring and Contamination Control September 11, 2015 Featured Speaker: Scott Sutton, Ph.D. The Microbiology Network N. Chili, New York 1 CE Activity Information & Accreditation
More informationMINIMUM REQUIREMENTS FOR A VENDOR
MINIMUM REQUIREMENTS FOR A VENDOR When outsourcing the production of sterile products the first step in vendor evaluation is to see if they meet the minimum requirements. We ve developed a group of questions
More informationUNDER SECRETARY FOR HEALTH S INFORMATION LETTER MICROBIOLOGICAL ASSESSMENT OF PHARMACEUTICAL CLEANROOMS
DEPARTMENT OF VETERANS AFFAIRS Veterans Health Administration Washington DC 20420 IL 10-2006-008 In Reply Refer To: 10NB UNDER SECRETARY FOR HEALTH S INFORMATION LETTER MICROBIOLOGICAL ASSESSMENT OF PHARMACEUTICAL
More information4.5 Compounding Compounding in Licensed Pharmacies.
0 0 0. Compounding. Compounding in Licensed Pharmacies. (a) Compounding means any of the following activities occurring in a licensed pharmacy, by or under the supervision of a licensed pharmacist, pursuant
More informationEnvironmental Control Requirements. Gordon Farquharson July 2017
Environmental Control Requirements Gordon Farquharson July 2017 Learning Objectives Learn how contamination control standards and guidance sets requirements for Critical Parameters ISO-14644-1 Classification
More informationCommissioning the ABSL-3 Laboratory
Commissioning the ABSL-3 Laboratory Michael C. Rosenberg P.E. Stanley Consultants Synopsis Airflow and pressurization relationships are adjusted and verified in most buildings with temperature / humidity
More information+ IQ/OQ Protocol Installation Qualification/ Operation Qualification
+ IQ/OQ Protocol Installation Qualification/ Operation Qualification Purifier Logic Series Biological Safety Cabinets Labconco o: 1058602 Rev. - Available at www.labconco.com or by e-mail in Word 2000
More informationRE: IACP Comments MA Proposed 247 CMR Sterile Compounding Regulations
Submitted at Reg.Testimony@state.ma.us November 29, 2017 David Sencabaugh, R.Ph. Executive Director Board of Registration in Pharmacy 239 Causeway Street, 5th Floor, Ste. 500 Boston, MA 02114 RE: IACP
More informationSterile Compounding Safety
Sterile Compounding Safety I International Congress on Patient Safety ISMP Brazil and V International Forum on Patient Safety: Medication Errors Eric S. Kastango, MBA, RPh, FASHP President/CEO Clinical
More informationHVAC and Risk Management RACI Meeting 7 th December Agenda. Design. Project Management. Context. Qualification. Construction
HVAC and Risk Management RACI Meeting 7 th December 2011 Dr Stephen Firmer Asia Pacific Consultants Pty Ltd Agenda Context Project Management Design Construction Qualification Routine Control /Potential
More informationPharmaceutical compounding standards. The minimum standards and technical equipment to be considered as adequate shall include: 1.
61-02-01-03. Pharmaceutical compounding standards. The minimum standards and technical equipment to be considered as adequate shall include: 1. Definitions. a. "Active chemical or ingredient" refers to
More informationPackaging Operations Technical Subcommittee
and Sterile About the Presenter John Derek Thompson Lead Sterile Engineer, DePuy Synthes Certified Professional with the IOPP Member of the Medical Device Technical Committee Chairman of the Member of
More informationRe: Insanitary Conditions at Compounding Facilities, Guidance for Industry (Docket ID: FDA-2016-D )
Division of Dockets Management (HFA-305) Food and Drug Administration Department of Health and Human Services 5630 Fishers Lane, Room 1061 Rockville, MD 20852 [Submitted electronically to www.regulations.gov]
More informationCompliance with USP 800
Compliance with USP 800 Patricia C. Kienle, RPh, MPA, FASHP Saad Dinno, BSPharm, RPh, FIACP, FACA International Seminar Houston, TX November 10 12, 2016 2016. All Rights Reserved. 1 Disclosure Patricia
More informationPI s Name Date Bldg./Rm#
PI s Name Date Bldg./Rm# Animal Biosafety Level 3 (ABSL-3) Yes No 1. Is access to the animal facility limited or restricted only to those persons authorized for program or support purposes? Yes No 2. Does
More informationDIVISION 11 - EQUIPMENT FOOD SERVICE EQUIPMENT LABORATORY FUME HOODS. A. Design Considerations
DIVISION 11 - EQUIPMENT 11400 FOOD SERVICE EQUIPMENT A. Design Considerations 1. The A/E shall use the services of a food service equipment specialist in preparation of kitchen areas and other food preparation
More informationChapter WAC Compounding Practices Crosswalk
Chapter 246-878 WAC Compounding Practices Crosswalk Draft WAC Language WAC 246-878-001 Purpose. 1) The requirements of this chapter apply to any person or facility that possesses a license under 18.64
More informationPreparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014
Preparing Your Aseptic Processing Facility for an FDA Inspection Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Agenda Regulatory Requirements Establishing your Approach Aseptic Controls
More informationHistory and Update of Chapters 797 and 800
United States Pharmacopeia (USP) History and Update of Chapters 797 and 800 Lisa D. Ashworth, BS Pharm, RPh, FACA 50 th Annual C.E. Seminar Saturday, January 27, 2018, Dallas, Texas Disclaimer The views
More informationWHAT IS A CLEAN ROOM?
WHAT IS A CLEAN ROOM? A clean room is an extremely sophisticated work environment, designed and built with the express purpose of providing a high level of cleanliness for a production or research facility.
More informationFabric & Finishes. Gordon Farquharson July 2017
Fabric & Finishes Gordon Farquharson July 2017 Every Cleanroom is a Prototype!! Process & Product has unique features The building and its environment are unique The equipment configuration is unique The
More informationPharmacy Compounding: Infection Prevention
Pharmacy Compounding: Infection Prevention Sam Eberwein, PharmD, MS, BCPS Clinical Manager, Sterile Products Area, Perioperative Services, & Special Formulations UNC Medical Center Department of Pharmacy
More informationUS Regulatory Requirements: Clinical & Clinical Research Production, SPECT & PET Radiopharmaceuticals (RPs)
US Regulatory Requirements: Clinical & Clinical Research Production, SPECT & PET Radiopharmaceuticals (RPs) 20 th International Symposium Radiopharmaceutical Sciences Jeju, Korea Pre-Symposium Workshop
More informationUSP <797> and Environmental Sampling
USP and Environmental Sampling Participants will be in listen only mode. 9 a.m. (PT) Download the PDF: https://www.emlab.com/m/media/usp797-webinar.pdf Presented by: Michael Berg, Ph.D. Continuing
More informationPHCT 401 Aseptic Processes & Techniques
PHCT 401 Aseptic Processes & Techniques Principles of Aseptic Techniques Aseptic Processing Sterility Testing Laminar flow air cleaning Quality Control Tests Personnel Principles of Aseptic Techniques
More informationModular Architectural Cleanroom Systems
Modular Architectural Cleanroom Systems the PORTAFAB ADVANTAGE Experience For over 30 years, PortaFab has been helping organizations with all of their cleanroom and environmental control needs. Our staff
More informationRisk Assessment and Preventive Measures Checklist for Construction and Renovation. Location of Construction: Project Start Date: Estimated Duration:
Risk Assessment and Preventive Measures Checklist for Construction and Renovation Location of Construction: Project Start Date: Estimated Duration: Project Manager (PM): Contractor(s): Infection Prevention
More informationBRIEFING 797 Pharmaceutical Compounding Sterile Preparations,
BRIEFING 797 Pharmaceutical Compounding Sterile Preparations, USP 41 page 6554 and PF 41(6) [Nov. Dec. 2015]. Based on the number and significance of public comments received in response to the revision
More information2008 USPC Official 5/1/08-7/31/08 General Chapters: <797> PHARMACEUTICAL... Page 1 of PHARMACEUTICAL COMPOUNDING STERILE PREPARATIONS
2008 USPC Official 5/1/08-7/31/08 General Chapters: PHARMACEUTICAL... Page 1 of 46 797 PHARMACEUTICAL COMPOUNDING STERILE PREPARATIONS INTRODUCTION This chapter provides procedures and requirements
More informationArchitectural Details. Walls. Including PVC cove, UL Listed Raceway, & Integration to Flooring. AES Pharma Wall & Walk-On Ceiling Cleanroom System
Architectural Details Section One Walls Including PVC cove, UL Listed Raceway, & Integration to Flooring AES Pharma Wall & Walk-On Ceiling Cleanroom System Architectural Components AES PHARMA SYSTEM AES
More informationModular Clean Room System
Modular Clean Room System The correct preparation and administration of compounded sterile preparations (CSPs) is a complex process that must be conducted by highly skilled professionals in a specialized
More informationContractor's Letter of Assurance
Contractor's Letter of Assurance Instructions WELL Certification is determined by onsite Performance Verification and documentation, including Letters of Assurance from the appropriate professionals overseeing
More informationSupplementary Training Modules on Good Manufacturing Practice. Validation. WHO Technical Report Series, No. 937, Annex 4.
Supplementary Training Modules on Good Manufacturing Practice Validation WHO Technical Report Series, No. 937, 2006. Annex 4. Validation Slide 1 of 48 August 2006 Validation! Part 1. General overview on
More informationSECTION INDOOR AIR QUALITY MANAGEMENT PLAN. A. PART A and DIVISION 1 of PART B are hereby made a part of this SECTION.
SECTION 018119 PART 1 GENERAL 1.01 GENERAL REQUIREMENTS A. PART A and DIVISION 1 of PART B are hereby made a part of this SECTION. B. Examine all conditions as they exist at the project prior to submitting
More informationVALIDATION AS A KEY TOOL IN SUCCESSFUL TRANSFER OR ESTABLISHMENT OF A MEDICAL DEVICE COMPANY IN A NEW FACILITY
VALIDATION AS A KEY TOOL IN SUCCESSFUL TRANSFER OR ESTABLISHMENT OF A MEDICAL DEVICE COMPANY IN A NEW FACILITY Oren Levin, Diane Gordon VisionCare Ophthalmic Technologies, POB 3879, Petah Tikva 49130,
More informationUSP<797> AND THE ASEPTIC PROCESSING OF RADIOPHARMACEUTICALS PART 1
USP AND THE ASEPTIC PROCESSING OF RADIOPHARMACEUTICALS PART 1 INTRODUCTION The learner was introduced to the guidelines of USP Chapter in a previous Continuing Education lesson, USP Compliance
More informationGood indoor air quality (IAQ) management has become paramount in the construction industry as study
Creating and Maintaining Good Indoor Air Quality Good indoor air quality (IAQ) management has become paramount in the construction industry as study after study shows that employee productivity and health
More informationNBC SPECIFICATIONS FOR CLEAN ROOM CERTIFICATION TESTING
The Narragansett Bay Commission Vincent J. Mesolella Corporate Office Building Chairman One Service Road Providence, RI 02905 Raymond J. Marshall, P.E. 401 461 8848 Executive Director 401 461 6540 FAX
More informationIssue Date: Effective Date:
Page 1 of 5 TITLE: STANDARD OPERATING PROCEDURE FOR BIOLOGICAL SAFETY CABINET CLASS I and CLASS II OPERATION AND MAINTENANCE CHAPTER: SOP #: 3-Equipment SF-3-05.02 Issue Date: Effective Date: SUPERSEDES
More informationHospital Pharmacy Isolator Solutions for USP <797> Compliance from Esco
Hospital Pharmacy Isolator Solutions for USP Compliance from Esco Contents 1. Introduction 2. Clean Air Devices and Isolators 3. Cytotoxic Exposure 4. Esco Pharmacy Isolator (Positive Pressure Model)
More informationMold Remediation. Containment guidelines: based on the size of the infected area.
Mold Remediation Containment guidelines: based on the size of the infected area. Level 1 (10 sq. ft. or less): e.g. ceiling tiles, small areas on walls Moldy materials that can be cleaned should be cleaned
More informationGuidance for Industry
Guidance for Industry Sterile Drug Products Produced by Aseptic Processing Current Good Manufacturing Practice U.S. Department of Health and Human Services Food and Drug Administration Center for Drug
More informationMetrology & Clean Room Technology (A complete practical course)
Metrology & Clean Room Technology (A complete practical course) In commemoration of world metrology day 2018 with the theme Constant evolution of the International System of Units, the academy of the International
More informationQUALITY ASSURANCE & AUDIT
QUALITY ASSURANCE & AUDIT Birinder Kaur Senior Pharmacist Pharmacy Dept National University Of Malaysia Medical Centre Kuala Lumpur birin@ppukm.ukm.edu.my LEARNING OBJECTIVES To define quality assurance
More informationPART 30: LABORATORIES
PART 30: LABORATORIES GENERAL REQUIREMENTS Definitions 30.7.1 In sections 30.8 to 30.11: laboratory fume hood operational face opening sash Laboratory fume hoods means an enclosed and mechanically ventilated
More informationThanks and acknowledgement to Pamela Isaacs for the content and slides in this presentation.
A PRESCRIPTION FOR INFECTION PREVENTION ROUNDING IN THE PHARMACY EVELYN COOK Thanks and acknowledgement to Pamela Isaacs for the content and slides in this presentation. OBJECTIVES: 1. Discuss recent outbreaks
More informationConstruction Indoor Air Quality (IAQ) Management Plan
Denver School of Science & Technology Middle School 2000 Valentia Street Denver, CO 80238 Telephone: 303-643-5775 Main Fax: 303-673-5776 Construction Indoor Air Quality (IAQ) Management Plan Denver School
More informationLessons to be Learned from the NECC 483
Lessons to be Learned from the NECC 483 Eric S. Kastango, MBA, RPh, FASHP President/CEO Clinical IQ, LLC and CriticialPoint,LLC Madison, NJ and Gaithersburg, MD Speaker Disclosures "Although Eric Kastango
More informationIsolators v. RABS: Facility Design Considerations for a Fill-Finish Finish Suite
APV 2008 Basle Conference Basle, Switzerland: May 28 & 29 2008 Isolators v. RABS: Facility Design Considerations for a Fill-Finish Finish Suite John R. Chester Principal Engineer Global Pharmaceutical
More information2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts
2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts 116 USP Update 2008 and Personnel-Related Environmental Sampling Trissel, L.A. TriPharma Research, P.O. Box 265, Cashiers,
More informationPost Sterilization Lab Contamination
Post Sterilization Lab Contamination PDA Midwest May 2018 Bob Stringham Microbiology Manager Overview > Ethylene Oxide sterilization utilizes Process Challenge Device (PCD) to support lot release > PCDs
More informationEnvironmental Monitoring of Aseptic Processing Areas - 1
Environmental Monitoring of Aseptic Processing Areas - 1 A war against an invisible enemy DCVMN - Víctor Maqueda - May 30, 31, June 1 2016 1 Training Course Agenda Overview of Environmental Monitoring
More informationEE-527: MicroFabrication
EE-527: MicroFabrication Clean Rooms How Big of a Particle is Tolerable? Example: 0.5 µm CMOS technology Lateral Features: pattern size = 0.5 µm pattern tolerance = 0.15 µm level-level registration = 0.15
More informationState of Kuwait Ministry of Health Infection Control Directorate. The role of infection control In design of health care facilities
State of Kuwait Ministry of Health Infection Control Directorate The role of infection control In design of health care facilities 2007 INTRODUCTION Hospital design should ensure that patients, especially
More informationAseptic Fill / Finish Facility Design for Compliance
Aseptic Fill / Finish Facility Design for Compliance Herman F. Bozenhardt Vantage Consulting Group October 2014 @ Copyright by Bozenhardt Consulting Services LLC 2014, Agenda Review Compliance Drivers
More informationINFECTION CONTROL ISSUES IN CONSTRUCTION AND RENOVATION
INFECTION CONTROL ISSUES IN CONSTRUCTION AND RENOVATION Evelyn Cook SPICE.unc.edu 919 966 1304 I want to begin with the premise that patients can leave the hospital sicker than they arrived if construction
More informationGuidance for Industry Sterile Drug Products Produced by Aseptic Processing Current Good Manufacturing Practice
Guidance for Industry Sterile Drug Products Produced by Aseptic Processing Current Good Manufacturing Practice DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments
More informationMicrobiology Testing: USP requirements for Sterile and Nonsterile Preparations Webinar Q&A
USP Antimicrobial Effectiveness Testing Microbiology Testing: Webinar Q&A 1. If a base ingredient is designed for the purpose of compounding a specific type of preparation does this forgo the necessity
More informationCLEAN ROOMS. Travaglini. Travaglini_inglese.indd 22 05/07/
CLEAN ROOMS Travaglini Travaglini_inglese.indd 05/07/ 5. Since 950, Travaglini S.p.A. has been a worldwide leader in the manufacturing of equipment for the production of sausages, hams and dairy products.
More informationCLASS I MICROBIOLOGICAL SAFETY CABINET - BIO 1
CLASS I MICROBIOLOGICAL SAFETY CABINET - BIO 1 PRODUCT SHEET NO. 101 VERSION 2.0 COMPACT HIGHLY SPECIFIED, HIGH PERFORMANCE CLASS I MICROBIOLOGICAL SAFETY CABINETS Applications Handling of biological agents
More informationJoint Committee Issue Paper
NSF Standard(s) Impacted: Background: Provide a brief background statement indicating the cause and nature of concern, the impacts identified relevant to public health, public understanding, etc, and any
More informationIndoor Air Quality and Mechanical Ventilation (Page 1 of 5)
Indoor Air Quality and Mechanical Ventilation (Page 1 of 5) Title 24, Part 6, Section 150.0(o) Ventilation for Indoor Air Quality. All dwelling units shall meet the requirements of ANSI/ASHRAE Standard62.2.
More information